Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
Author:
Norikazu Masuda,Yasuaki Sagara,Takayuki Kinoshita,Hiroji Iwata,Seigo Nakamura,Yasuhiro Yanagita,Reiki Nishimura,Hirotaka Iwase,Shunji Kamigaki,Hiroyuki Takei,Shinzaburo Noguchi
Publication:
The Lancet Oncology
Copyright © 2012 Elsevier Ltd. All rights reserved.